136 related articles for article (PubMed ID: 8241953)
1. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation.
Robinson S; Lenfant M; Wdzieczak-Bakala J; Riches A
Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953
[TBL] [Abstract][Full Text] [Related]
2. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation.
Thierry J; Grillon C; Gaudron S; Potier P; Riches A; Wdzieczak-Bakala J
J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549
[TBL] [Abstract][Full Text] [Related]
4. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.
Robinson S; Lenfant M; Wdzieczak-Bakala J; Melville J; Riches A
Cell Prolif; 1992 Nov; 25(6):623-32. PubMed ID: 1457609
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
Chisi JE; Wdzieczak-Bakala J; Riches AC
Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658
[TBL] [Abstract][Full Text] [Related]
7. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M
Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
[TBL] [Abstract][Full Text] [Related]
8. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE
Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
[TBL] [Abstract][Full Text] [Related]
9. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
Rousseau-Plasse A; Wdzieczak-Bakala J; Lenfant M; Ezan E; Genet R; Robinson S; Briscoe T; Melville J; Riches A
Exp Hematol; 1998 Oct; 26(11):1074-9. PubMed ID: 9766448
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the adherence of hematopoietic stem cells to mouse bone marrow-derived stromal cell line MS-1-T by a tetrapeptide acetyl-N-Ser-Asp-Lys-Pro.
Lenfant M; Itoh K; Sakoda H; Sotty D; Sasaki NA; Wdzieczak-Bakala J; Mori KJ
Exp Hematol; 1989 Sep; 17(8):898-902. PubMed ID: 2767182
[TBL] [Abstract][Full Text] [Related]
11. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of tetrapeptide AcSDKP on hemopoietic cell binding to the stromal cell in vitro.
Aizawa S; Toyama K; Mori KJ; Frindel E
Exp Hematol; 1992 Aug; 20(7):896-9. PubMed ID: 1628708
[TBL] [Abstract][Full Text] [Related]
13. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP.
Coutton C; Guigon M; Bohbot A; Ferrani K; Oberling F
Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774
[TBL] [Abstract][Full Text] [Related]
14. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP].
Han Z; Cai Y; Aidoudi S
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842
[TBL] [Abstract][Full Text] [Related]
15. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
[TBL] [Abstract][Full Text] [Related]
16. Enhanced engraftment of intravenously transplanted hematopoietic stem cells into bone marrow of irradiated mice treated with AcSDKP.
Suzuki A; Aizawa S; Araki S; Hoshi H; Nakano M; Kimura Y; Toyama K
Exp Hematol; 1998 Jan; 26(1):79-83. PubMed ID: 9430517
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) analogs resistant to angiotensin I-converting enzyme on hematopoietic stem cell and progenitor cell proliferation.
Gaudron S; Grillon C; Thierry J; Riches A; Wierenga PK; Wdzieczak-Bakala J
Stem Cells; 1999; 17(2):100-6. PubMed ID: 10195570
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2, and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action.
Lauret E; Dumenil D; Miyanomae T; Sainteny F
Exp Hematol; 1989 Dec; 17(11):1081-5. PubMed ID: 2583252
[TBL] [Abstract][Full Text] [Related]
19. Development of an enzyme immunoassay for a stable amidated analog of the hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro.
Junot C; Theodoro F; Thierry J; Clement G; Wdzieczak-Bakala J; Ezan E
J Immunoassay Immunochem; 2001; 22(1):15-31. PubMed ID: 11486817
[TBL] [Abstract][Full Text] [Related]
20. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.
Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E
Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
